299 related articles for article (PubMed ID: 28867201)
21. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
22. Mannitol-sucrose mixtures--versatile formulations for protein lyophilization.
Johnson RE; Kirchhoff CF; Gaud HT
J Pharm Sci; 2002 Apr; 91(4):914-22. PubMed ID: 11948529
[TBL] [Abstract][Full Text] [Related]
23. The formation and effect of mannitol hemihydrate on the stability of monoclonal antibody in the lyophilized state.
Anko M; Bjelošević M; Planinšek O; Trstenjak U; Logar M; Ahlin Grabnar P; Brus B
Int J Pharm; 2019 Jun; 564():106-116. PubMed ID: 30999044
[TBL] [Abstract][Full Text] [Related]
24. Implementation of a process analytical technology system in a freeze-drying process using Raman spectroscopy for in-line process monitoring.
De Beer TR; Allesø M; Goethals F; Coppens A; Heyden YV; De Diego HL; Rantanen J; Verpoort F; Vervaet C; Remon JP; Baeyens WR
Anal Chem; 2007 Nov; 79(21):7992-8003. PubMed ID: 17896825
[TBL] [Abstract][Full Text] [Related]
25. Mannitol hemihydrate in lyophilized protein formulations:Impact of its dehydration during storage on sucrose crystallinity and protein stability.
Sonje J; Thakral S; Mayhugh B; Sacha G; Nail S; Srinivasan J; Suryanarayanan R
Int J Pharm; 2022 Aug; 624():121974. PubMed ID: 35787458
[TBL] [Abstract][Full Text] [Related]
26. Modeling of heat and mass transfer processes for the gap-lyophilization system using the mannitol-trehalose-NaCl formulation.
Kuu WY; Doty MJ; Nisipeanu E; Rebbeck CL; Cho YK; Smit MH
J Pharm Sci; 2014 Sep; 103(9):2784-2796. PubMed ID: 24648334
[TBL] [Abstract][Full Text] [Related]
27. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
28. Mutual Influence of Mannitol and Trehalose on Crystallization Behavior in Frozen Solutions.
Jena S; Suryanarayanan R; Aksan A
Pharm Res; 2016 Jun; 33(6):1413-25. PubMed ID: 26908047
[TBL] [Abstract][Full Text] [Related]
29. Existence of a mannitol hydrate during freeze-drying and practical implications.
Yu L; Milton N; Groleau EG; Mishra DS; Vansickle RE
J Pharm Sci; 1999 Feb; 88(2):196-8. PubMed ID: 9950638
[TBL] [Abstract][Full Text] [Related]
30. Mannitol as an Excipient for Lyophilized Injectable Formulations.
Thakral S; Sonje J; Munjal B; Bhatnagar B; Suryanarayanan R
J Pharm Sci; 2023 Jan; 112(1):19-35. PubMed ID: 36030846
[TBL] [Abstract][Full Text] [Related]
31. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.
Kim AI; Akers MJ; Nail SL
J Pharm Sci; 1998 Aug; 87(8):931-5. PubMed ID: 9687336
[TBL] [Abstract][Full Text] [Related]
32. Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization.
Cao W; Xie Y; Krishnan S; Lin H; Ricci M
Pharm Res; 2013 Jan; 30(1):131-9. PubMed ID: 22907420
[TBL] [Abstract][Full Text] [Related]
33. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
Grohganz H; Lee YY; Rantanen J; Yang M
Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
[TBL] [Abstract][Full Text] [Related]
34. Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol--implications in freeze-drying.
Liao X; Krishnamurthy R; Suryanarayanan R
Pharm Res; 2005 Nov; 22(11):1978-85. PubMed ID: 16132343
[TBL] [Abstract][Full Text] [Related]
35. Crystallization of mannitol below Tg' during freeze-drying in binary and ternary aqueous systems.
Pyne A; Surana R; Suryanarayanan R
Pharm Res; 2002 Jun; 19(6):901-8. PubMed ID: 12134964
[TBL] [Abstract][Full Text] [Related]
36. Development of freeze-dried biosynthetic Factor VIII: I. A case study in the optimization of formulation.
Jameel F; Tchessalov S; Bjornson E; Lu X; Besman M; Pikal M
Pharm Dev Technol; 2009; 14(6):687-97. PubMed ID: 19883259
[TBL] [Abstract][Full Text] [Related]
37. Significant Drying Time Reduction Using Microwave-Assisted Freeze-Drying for a Monoclonal Antibody.
Gitter JH; Geidobler R; Presser I; Winter G
J Pharm Sci; 2018 Oct; 107(10):2538-2543. PubMed ID: 29890173
[TBL] [Abstract][Full Text] [Related]
38. Anomalous behavior of mannitol hemihydrate: Implications on sucrose crystallization in colyophilized systems.
Thakral S; Sonje J; Suryanarayanan R
Int J Pharm; 2020 Sep; 587():119629. PubMed ID: 32653598
[TBL] [Abstract][Full Text] [Related]
39. Application of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgG.
Daneshmand B; Faghihi H; Amini Pouya M; Aghababaie S; Darabi M; Vatanara A
Pharm Dev Technol; 2019 Apr; 24(4):439-447. PubMed ID: 30070161
[TBL] [Abstract][Full Text] [Related]
40. Influence of ethanol on physical state of freeze-dried mannitol.
Takada A; Nail SL; Yonese M
Pharm Res; 2009 May; 26(5):1112-20. PubMed ID: 19184373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
